Therapeutic Anticoagulation with Argatroban and Heparins Reduces Granulocyte Migration: Possible Impact on ECLS-Therapy?

Figure 1

Comparison of track length medians of the verum groups with the control group at the observation time periods: 0–60 min (a), 61–120 min (b), 121–180 min (c), and 181–240 min (d). Cont: control; Arga: argatroban; LMWH: low-molecular-weight heparin; UFH: unfractionated heparin.

(a)

(b)

(c)

(d)